ClinicalTrials.gov
public full text
Public Domain
Three Month Course of Anti-HIV Medications for People Recently Infected With HIV
Short-term therapy may reduce the amount of HIV in the blood of adults recently infected with HIV. The purpose of this study is to see whether it is better for people to take a short course of anti-HIV drugs when they are first infected or if it is better to wait until the HIV infection causes health problems before taking anti-HIV drugs.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cardiovascular Prevention for Persons With HIV#1194775
- Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis#1170901
- Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico#982304
- Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy#995540
- Impaired Kidney Function in People Living with HIV, Taking into Account Socioeconomic Factors, Lifestyle, and Nephrotoxic Drugs: Population-Based CONSTANCES Cohort#159218
Record · ID 1351712
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive